Numerous studies demonstrate that ADN functions as an anti-inflammatory agent and participates in improvement of metabolic inflammatory diseases, such as type 2 diabetes, obesity, and cardiovascular diseases [36–38]. This evidence concerns the gene CFD and obesity due to melanocortin 4 receptor deficiency.